Company · CIK 1828326

# Frazier Lifesciences Acquisition Corp

| CIK | [1828326](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001828326) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 6770 — Blank Checks |
| Incorporated in | E9 |
| Business address | WA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-26 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-250858 | SPAC Final prospectus | 2020-11-20 | 2020-12-10 | 3 |

## Filings

 4

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2020-12-10 | [424B4](https://www.sec.gov/Archives/edgar/data/1828326/000110465920134286/0001104659-20-134286-index.htm) Final prospectus | 333-250858 | 0001104659-20-134286 |
| 2020-12-08 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1828326/999999999520003445/9999999995-20-003445-index.htm) Declared effective | 333-250858 | 9999999995-20-003445 |
| 2020-11-20 | [S-1](https://www.sec.gov/Archives/edgar/data/1828326/000110465920128041/0001104659-20-128041-index.htm) Registration filed | 333-250858 | 0001104659-20-128041 |
| 2020-10-15 | [DRS](https://www.sec.gov/Archives/edgar/data/1828326/000110465920115324/0001104659-20-115324-index.htm) Draft made public | 377-03670 | 0001104659-20-115324 |

[All filings of this company](https://equitycapital.markets/filings?cik=1828326) · [CSV](https://equitycapital.markets/filings.csv?cik=1828326)

---
Source page: https://equitycapital.markets/company/1828326 · Data: U.S. SEC EDGAR · CC BY 4.0